Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q9NZC3
UPID:
GDE1_HUMAN
Alternative names:
Glycerophosphoinositol glycerophosphodiesterase GDE1; Lysophospholipase D GDE1; Membrane-interacting protein of RGS16; RGS16-interacting membrane protein
Alternative UPACC:
Q9NZC3; O43334; Q6PKF7; Q7KYR4
Background:
Glycerophosphodiester phosphodiesterase 1 (GDE1) plays a crucial role in cellular metabolism by hydrolyzing glycerophosphodiesters to yield glycerol phosphate and an alcohol. It is involved in the biosynthesis of bioactive N-acylethanolamines, including anandamide, N-palmitoylethanolamine, and N-oleoylethanolamine, which are critical for brain function. GDE1's activity extends to lysophospholipase D, albeit at a lower rate, contributing to its multifaceted role in biological systems.
Therapeutic significance:
Understanding the role of Glycerophosphodiester phosphodiesterase 1 could open doors to potential therapeutic strategies.